BLOOMFIELD, Conn., July 31, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today reported strong second quarter 2025 results, reflecting continued growth and solid performance across its diverse portfolio of businesses. "Listening, adapting, and innovating to meet the evolving needs of our patients, customers, and clients enables us to deliver meaningful value," said David M. Cordani, chairman and CEO of The Cigna Group. "Our performance in the second quarter reflects our disciplined ...

Core Insights - Cigna Group reported first-quarter 2025 revenue of $65.45 billion, exceeding analyst estimates of $60.39 billion, with a year-over-year sales increase of 14% driven by existing client relationships and strong growth in specialty pharmacy services [1] - Adjusted earnings per share were $6.74, surpassing analysts' expectations of $6.35 [1] Revenue Breakdown - Evernorth Health Services, which includes Pharmacy Benefit and Specialty and Care Services, achieved first-quarter sales of $53.68 billion, reflecting a 16% increase [2] - Cigna Healthcare segment sales rose 9% to $14.48 billion, primarily due to premium rate increases to cover expected medical cost increases [3] Customer Metrics - Total medical customers decreased by 6% from December 31, 2024, to 18.04 million, largely due to the impact of the HCSC transaction; however, excluding this impact, customer numbers remained stable [4] - Total customer relationships reached 182.2 million as of March 31, 2025, with a 1% increase when excluding the HCSC transaction [4] - Total pharmacy customers increased by 3% to 122.3 million, attributed to new sales and expanded relationships [4] Future Outlook - Cigna anticipates fiscal 2025 adjusted income per share of $29.60, slightly up from the previous estimate of $29.50, aligning with consensus expectations [5] - Evernorth's adjusted income from operations is projected to be at least $7.2 billion, with Cigna Healthcare expected to contribute at least $4.125 billion [5] Financial Ratios - The Cigna Healthcare Medical Care Ratio (MCR) is expected to range between 83.2% to 84.2% [6] - The MCR for the first quarter of 2025 was reported at 82.2%, an increase from 79.9% a year ago, primarily due to higher stop-loss medical costs [7]

Core Insights - The Cigna Group reported strong first quarter 2025 results, with significant growth across its diversified business portfolio, leading to an increased outlook for full-year earnings [1][2][20] Financial Performance - Shareholders' net income for Q1 2025 was $1.3 billion, or $4.85 per share, compared to a net loss of $0.3 billion, or $0.97 per share, in Q1 2024 [2][7] - Adjusted income from operations for Q1 2025 was $1.8 billion, or $6.74 per share, slightly down from $1.9 billion, or $6.47 per share, in Q1 2024 [3][7] - Total revenues for Q1 2025 increased by 14% to $65.5 billion compared to Q1 2024, driven by growth in existing client relationships and specialty pharmacy services [4][7] Customer Relationships - Total customer relationships as of March 31, 2025, were 182.2 million, reflecting a 1% increase excluding the impact of the HCSC transaction [15] - Total pharmacy customers increased by 3% to 122.3 million, while total medical customers decreased by 6% to 18.0 million, primarily due to the HCSC transaction [15][6] Segment Performance - Evernorth Health Services reported adjusted revenues of $53.7 billion for Q1 2025, with a 16% increase in adjusted income from operations, pre-tax [16] - Cigna Healthcare's adjusted income from operations, pre-tax, was $1.3 billion for Q1 2025, reflecting a slight decrease from the previous year [37] Outlook - The Cigna Group's outlook for full-year 2025 adjusted income from operations is projected to be at least $29.60 per share, an increase of $0.10 from prior projections [20][21]